You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Anti-biofilm agents for the treatment of pulmonary infection in cystic fibrosis p
SBC: AGILE SCIENCES, INC. Topic: NIAIDDESCRIPTION provided by applicant The leading cause of mortality in patients with cystic fibrosis CF is pulmonary failure from lung infections and the predominant organism isolated from these infections is the bacterium Pseudomonas aeruginosa Lung infections of CF patients persist over the lifetime of the patients and are impossible to eradicate due to the ability of bacteria to form biofi ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
A Rapid assay for RNA targeted drugs: Instrumentation Supplement
SBC: NUBAD LLC Topic: 300DESCRIPTION provided by applicant Some of the most significant therapies that treat disease target nucleic acids Drugs that target nucleic acid include cancer drugs antibiotics and antivirals Combined these classes of drugs have annual sales worldwide of $ billion Antibiotics that target nucleic acids account for $ billion of the $ billion of sales annuall for all antibiotics an ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
A Quantitative Optical Sensor to Monitor Tumor Vascular Physiology
SBC: Zenalux Biomedical, Inc. Topic: 102DESCRIPTION provided by applicant In there were new cases of head and neck cancers HNC in the United States Early detection of new and locally recurrent cancers is clinically important to reduce not only cancer related mortality but also treatment associated morbidity as it impacts multiple organ functions including respiration olfaction hearing eating swallowing and speak ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
An Early-Phase Clinical Trial Evaluating ABC294640 in Patients with Refractory/Re
SBC: Apogee Biotechnology Corporation Topic: 102DESCRIPTION provided by applicant Diffuse large B cell lymphoma DLBCL represents one of the most common variants of Non Hodgkinandapos s lymphoma NHL and oncogenic herpesviruses EBV and KSHV are the etiologic agents for the majority of these tumors in patients over or those infected with the human immunodeficiency virus HIV Despite modest improvements in outcomes for patients rece ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Post Intercept Debris Predictions for Electro-Optical and Infrared (EO/IR) Scene Modeling
SBC: CORVID TECHNOLOGIES, LLC Topic: MDA12T005Corvid Technologies is pleased to offer this STTR Phase II proposal in collaboration with The Johns Hopkins University Applied Physics Laboratory (JHU/APL), Spectral Sciences Inc. and Torch Technologies. Capabilities from each collaborator are being combined toward the ability to perform accurate, fast-running electro-optical and infrared (EO/IR) signature predictions. This collaborative effort ...
STTR Phase II 2014 Department of DefenseMissile Defense Agency -
Novel Extensible Design Approaches for Advanced Aircraft Composite Structural Architectures (MSC P4168)
SBC: MATERIALS SCIENCES LLC Topic: ST13A006Among the factors that inhibit the use of composite materials in both general aviation aircraft and DoD platforms are the relatively high cost of engineering and certification. Unless manufacturers control risk when introducing new or advanced materials and processes for aircraft, the potential benefits will be lost to the industry. For small commercial applications the problem is compounded by ...
STTR Phase II 2014 Department of DefenseDefense Advanced Research Projects Agency -
Assessing the Bite Counter as a Tool for Food Intake Monitoring: Phase II
SBC: BITE TECHNOLOGIES, LLC Topic: 300DESCRIPTION provided by applicant Self monitoring has been described as the andquot cornerstone of the behavioral treatment of obesityandquot Consistent self monitoring of energy intake is associated with improved dietary adherence and weight loss and maintenance The problem is that individuals are notoriously bad at self monitoring their intake and suffer from an underreporting bias The s ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Reversal of Myocardial Infarction by Localized Stimulation
SBC: Micro Vide, LLC Topic: NHLBIDESCRIPTION provided by applicant Heart attacks i e myocardial infarction or MI occur in more than million patients annually Advances in pharmacological therapy have dramatically improved survival following the initial MI Consequently the number of patients with previous MI continues to increase and as a result put in jeopardy millions of patients for development of heart failure I ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Real Time 3-D Modeling and Immersive Visualization for Enhanced Soldier Situation Awareness
SBC: Carnegie Robotics LLC Topic: A12aT003We propose a rapid mapping and 3-D visualization system especially suited for inside buildings, tunnels, urban canyons, and other environments where GPS may be poor or not available. The system--which was fully demonstrated in our Phase I effort-- includes mobile Sensor Nodes that wirelessly supply compressed 3D range data and color imagery to a central Fusion Node. The Fusion Node runs 3D recon ...
STTR Phase II 2014 Department of DefenseArmy -
Developing Intravesical Liposomes for Interstitial Cystitis
SBC: Lipella Pharmaceuticals Inc. Topic: NIDDKDESCRIPTION (provided by applicant): Lipella Pharmaceuticals Inc. (Pittsburgh, PA) is a clinical-stage pharmaceutical company specializing in intravesical therapies for urinary bladder dysfunctions. Lipella is submitting a research proposal to the Small Business Technology Transfer program titled Developing Intravesical Liposomes for Interstitial Cystitis . The project proposes to evaluate the sa ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health